Topic Archives: Ebola

Comments

  • Avatar

    Very interesting discussion of Ebola and the Epidemic that came to NYC. I actually have a method for treating an individ...

  • Avatar

    From The Hill (today): "At least ten health care workers have been infected with the deadly Ebola virus as they battl...

  • arch1

    That was MK ultra. Mention of that a few years ago would get you accused of the tinfoil helmet crowd, but FOIA release o...

  • Avatar

    My dear Javi, what is truly important is that Dr. Thomas Frieden's last minute launch of a campaign agains pain patients...

  • Avatar

    Hopeful short article by Ed Yong on DRC's successful containment of its latest Ebola outbreak. Interestingly, tweeting i...

  • Dr. KSS MD PhD

    Sorry, yes it is ABX-464. Other than parking in the stock, which I have done, I have to admit I don't have a sense of cl...

  • Dr. KSS MD PhD

    Your link won't open. However, in general monoclonal antibodies have failed against the major RNA viruses HIV and HCV wh...

  • Avatar

    $Ebola outbreak In the Congo.........On April 22, 2017 a 30 year old man was referred to a hospital after presenting ...

  • arch1

    Some new info on Ebola epidemic; "We calculated that 3.6 percent of cases traveled, basically meaning that if you wer...

  • Avatar

    The vaccine was developed in Canada but is now owned and manufactured by Merck, Sharp & Dohme. It's currently being ...

  • Avatar

    Actually, you were wrong :) Ebola vaccine gives 100% protection, study finds http://www.cnn.com/2016/12/22/healt...

  • arch1

    glenn Thanks. Here is link to full text Lancet article; http://www.thelancet.com/journals/lancet/article/PIIS0140-673...

  • Avatar

    WSJ today: "Writing in the journal the Lancet, an international consortium released the final results of an experiment ...

  • DBMD

    From Fiercebiotech on UN view of R&D in biotech. More government, since they know best. Home Biotech Biopharma...

  • Dr. KSS MD PhD

    Any day now we'll get the ursine case for Arch from Gbola Amusa ("Ebola Enuresis") at Chardan Capital....

  • Avatar

    Hi, Ben. That was a good write up in the NEJM. Viral causes of uveitis can produce very unusual clinical pictures. In th...

  • Travis Johnson, Stock Gumshoe

    I don't blame you, the teased picks based on expected trial or FDA news don't seem to be right about the direction any m...

  • Travis Johnson, Stock Gumshoe

    Yes, they've been teasing it for a while: http://www.stockgumshoe.com/reviews/alternative-energy-speculator/the-biggest-...

  • Avatar

    $ARTH (long) Anesthesiologist with 30+ yrs experience (22nowind) further observed on comments page of SA article cited ...

  • arch1

    I think $7777 would not count as infringement. They are selling a hydrogel. Jello is a hydrogel. $arth is more like Sara...

  • Avatar

    The company cannot seem to pull it off, but Aethlon Medical has a device that cleans the blood of the virus load allowin...

  • sogiam

    #Zika (copied from Michael's virus thread): ...Also, it is an insult to intelligence and underhanded to lump Zika in wi...

  • Avatar

    "even when the current flu vaccine is not precisely spot on, it is at least to some degree effective.......The vaccine m...

  • sogiam

    White House to Shift About $500 Million for Fighting Ebola to Combating Zika Says necessary because Congress hasn't act...

  • arch1

    Ben posted this link on the Pliny thread and I am taking the liberty of posting it here for further discussion; http://...

  • Avatar

    As a rule I take large positions in stocks that I buy. I simply am not a believer in diversification. Again one mans opi...

  • Avatar

    Hey Doc, Any thoughts about Athelon Medical and the fight against virus? I believe their device was instrumental in th...

  • Avatar

    I have written osure tech and the cdc to set up testing centers at points of entry to tthe USA to prevent the spread of ...

  • Dr. KSS MD PhD

    It's a little tough to say yet how much trouble Zika will cause. It's a flavivirus related to dengue and Chikungunya, an...

  • Travis Johnson, Stock Gumshoe

    Thanks for the thoughtful comments -- I generally agree and think many GMO advances are, on balance, worth the risk and ...

  • Avatar

    Anamorph - thanks. Agree in nearly all respects. However, I believe it is also important not to overstate the effecti...

  • Avatar

    I am not sure why you mean by fishy, dcohn, but ebola does seem to have reappeared. http://www.breitbart.com/national-s...

  • Anamorph

    Well said D Brown. Ebola has horrible symptoms and is easily spread, and there's much not known about it. But there ...

  • Avatar

    I can start an answer. Good questions and a fascinating topic. But it's not odd at all! The very short, over-simplifi...

  • Avatar

    The whole Ebola thing has be very much confused. Why did it stop. How did they stop it. How did it start. Why didn't...

  • Dr. KSS MD PhD

    Vaccine companies tend not to pass on jingle to their investors. That's my estimation after pulling charts on what few e...

  • arch1

    Continuing what I began concerning ISIS or IS. When an opening is left for brutality,brutality will grow to fill it. A...

  • Avatar

    Here is an excerpt from today’s WAPO article reporting that the mortality rate for white men and women ages 45-54 with...

  • arch1

    Autumn is a second spring where every leaf is a flower…… Albert Camus French philosopher much influenced by Sarte, ...

  • Dr. KSS, MD PhD

    Great scientific coverage of what we have learned about the Ebola problem in Africa in present issue of Nature. http://w...

  • Avatar

    Hepatitis B Vaccine... ABIVAX DEVELOPS NOVEL MEDICINES TO CONTROL LIFE-THREATENING VIRAL DISEASES ABIVAX is a biote...

  • Avatar

    Canada continues to develop critical medicines for no payout... The strange tale of Canada’s ebola vaccine Commercia...

  • Dr. KSS, MD PhD

    Frank...yes humanitarian plus PR, but also there is the fact that devising this vaccine beefed up MRK's vaccine expertis...

  • arch1

    DR KSS In re $merk Ebola vaccine; Interview with DR. Henry Miller of Stanford and formerly with FDA ,,says 100% efficacy...

  • Dr. KSS, MD PhD

    Lancet: $MRK Ebola vaccine 100 percent effective in phase 3 trial in Guinea at interim analysis. The vaccine was base...

  • Dr. KSS, MD PhD

    They certainly now have a full house of HBV strategies on their board, few of them tested. I wish Tekmira would be less ...

  • DBMD

    The reason HCV needs a Benitec cure. I thought that Benitec would run out of patients for their trials because of Solval...

  • Avatar

    Re: MERS US officials calling the country grossly unprepared for a MERS epidemic. Reminds me of the Ebola scare and the...

  • DBMD

    From Oxidation for Health thread: September 3, 2014 at 3:18 pm Jack: I did, and I officially hereby revise that to ...

  • sogiam

    ARNI-FLEMINGTON, N.J., June 3, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharma...

  • DBMD

    I meant to mention a KSS quote in regard to GBIM from the Ebola thread: "I don’t regard Tarmogens, which Gilead is in...

  • Avatar

    I was wondering the same thing. If Ebola has a 50% fatality rate (I thought it was closer to 90%) then 1,000 times that...

  • Avatar

    You have to laugh at the hype: "...more prevalent than Ebola… and 1,000 times more deadly.” If Ebola kills ½ of t...

  • Avatar

    $New Teaser Email Has Travis covered this? A bit more harsh/alarming than most teasers. CDC Targets Silent Killer...

  • Avatar

    Great find. I am amazed to see this. There is more to Ebola that meets the eye. Glad they took the prescribed precaution...

  • Avatar

    FWIW: Interesting tidbit about Ebola... even though you can be cleared as Dr Crozier was supposedly, it may still be in ...

  • Avatar

    Some news that may affect $TKMR - success treating monkeys with Ebola: http://www.bbc.com/news/world-32424145...

  • arch1

    Larry I thought this was one we discussed early on in Liberia Ebola outbreak,,,,I could not find it but here is recent n...

  • sogiam

    IMMVF-Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine program...

  • Avatar

    Health related with some politics thrown in (sorry Alan - but it's humorous): A Newly Defined Disease is Found to be...

  • Dr. KSS, MD PhD

    Hi Steve...not an unreasonable query, and great observations. Certainly it almost looks mo-mo-ey here, and insiders have...

  • Dr. KSS, MD PhD

    Yes, but they utterly failed to execute....they did not try to insinuate themselves into that situation. And frankly, no...

  • Avatar

    #HEB Has anyone else been watching Hemispherix. I know it was talked about way back when. I didn't know they were wor...

  • Avatar

    To start with the - probably - obvious Rae, make sure you have either a price alert set on your broker site - if it's a ...

  • Patricia

    Having worked in hospitals, I can appreciate the value and potential of their product. I spent some time last night look...

  • Michael Jorrin (aka Doc Gumshoe)

    If you have to use a 16 foot ladder to change your light bulbs, switch to AeroTech bulbs, super rough service, that will...

  • Dr. KSS, MD PhD

    An interesting thought, but for sake of devil's advocacy, keep in mind that the clinical utility of RNAi still hasn't re...

  • Avatar

    EBOLA CURE ? What do you think of this? Could this be a money maker? Ebola cure. This company made a filter that cu...

  • Avatar

    Former Army Ebola researcher is the Time Magazine 2014 person of the year fighting the war of Ebola. http://www.army.mi...

  • Dr. KSS, MD PhD

    Thanks seeking for great coverage of $BCRX. Make no mistake about it...this is one good virology company. It is in centr...

  • Avatar

    Hi Doc, Some interesting press releases on BioCryst BioCryst Receives Orphan Drug Designation for BCX4161 for th...

  • Dr. KSS, MD PhD

    I got a nice email this am from Josephus Weeks. He is the brother of Thomas Eric Duncan, the African man who died in Dal...

  • DBMD

    ABIO (mentioned Tiny BioTech) Lots of news accounting for uptick rNAPc2 Previously Demonstrated Post-Exposure Efficacy...

  • sogiam

    Money Morning-Biotech Insider-He provides a list of 5 companies (not specific of course) he's touting; Three are Ebola-...

  • Avatar

    Alan KSS Post 352 on Ebola article: Also, to run my list for anyone interested: Long positions: sentiment Achaogen ...

  • analog68

    I have yet to make a single move based on anything DH says but I follow him for info purposes. He took a position in RG...

  • Avatar

    CMRX - Chimerix This is a nice chart. From 14 to 35 in the last year. Working on an Ebola treatment. Chimerix's ...

  • Avatar

    In case anyone out there is wondering what alternative treatments are out there for ebola, it seems ozone treatment, ult...

  • Avatar

    I'll also comment upon "What else is necessary to contain the Ebola virus?" Frankly, the most important thing is to educ...

  • Avatar

    Overall, this is a good essay, Doc Gumshoe. But as a physician I take exception to a few issues. Primarily, I disagree w...

  • Avatar

    Good news for $CERS. FDA OK's IDE for Cerus' system for treating convalescent plasma for Ebola patients • 9:25 AM ...

  • duped

    CTIC has had about 4 reverse stock splits. Check out Adam F's opinion of their CEO Jim Bianco. Thinks he may be the "w...

  • Avatar

    The FDA holds a lot of cards. When I ask the famous "follow the money" question, I sometimes feel I'm a conspiracy theo...

  • Avatar

    Thanks Om, I will take a look at that.Interesting little company and with the Time magazine article they are getting not...

  • Michael Jorrin (aka Doc Gumshoe)

    Firefly DX so far is able to detect several common pathogens - flu, MRSA, HPV, etc - & presumably can be programmed ...

  • Avatar

    Has anyone heard of this stock PSID? Would love to hear your take on this. DELRAY BEACH, Fla., Oct. 16, 2014 (GLOBE NE...

  • DBMD

    The Reston strain is not pathogenic in humans, but is resp spread among humans. The infection did come from primates, an...

  • Avatar

    Gummies, as to Doc Gumshoes # 1 comment, what was the ticker for the Company which is devising the test for Ebola CEMI ?...

  • Michael Jorrin,

    Many thanks for the comments. Here are some comments on the comments: 1) In general, I am highly skeptical that any ...

  • Dr. KSS, MD PhD

    A perspicacious read, Michael, and thank you. News is that India is wrestling with the circumstances of an infected ...

  • Avatar

    I've read that in Sierra Leone, a government approved, successful Ebola treatment involves the use of Colloidial Silver...

  • Avatar

    a good job by "doc" but did you notice how most of the commentary went off-subject? I think that is because the whole m...

  • Avatar

    I'm surprised in all the news about Ebola to find no mention of Cerus's (CERS) Intercept System for various blood produc...

  • Avatar

    http://m.seekingalpha.com/news/2123605 Links to the 3 companies with ties to Ebola point of care testing. It seems b...

  • Avatar

    i have been long CEMI (Chembio Diagnostics) for years due to their Point of care diagnostics test for AIds. They are no...

  • Avatar

    Our incompetent government will destroy the USA...not only thru the economic travesty they call the economy but their tr...

  • DBMD

    There is another death from a man from Sierra Leone, who presented to Nebraska after 13 days of illness late in the cour...

  • Avatar

    Re: AMGN and S&A "Pitch". I haven't seen a pitch on this. But AMGN was written up in the Nov., 2014 Stansberry's Inv...

  • Avatar

    Have you seen the teaser from the folks at s&A regarding Ebola vaccine and heart disease vaccines. The answer is A...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch